Trapidil
Trapidil is a vasodilator and an antiplatelet drug.[1][2] It also acts as an antagonist of platelet-derived growth factor.[3]
![]() | |
Clinical data | |
---|---|
Trade names | Rocornal, Avantrin, Travisco |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.035.834 ![]() |
Chemical and physical data | |
Formula | C10H15N5 |
Molar mass | 205.26 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
![]() ![]() |
References
- Büyükafşar, K; Yazar, A; Düşmez, D; Oztürk, H; Polat, G; Levent, A (October 2001). "Effect of Trapidil, an Antiplatelet and Vasodilator Agent on Gentamicin-Induced Nephrotoxicity in Rats". Pharmacological Research. 44 (4): 321–8. doi:10.1006/phrs.2001.0864. PMID 11592868.
- Liu, M; Sun, Q; Wang, Q; Wang, X; Lin, P; Yang, M; Yan, Y (March–April 2014). "Effect of Trapidil in Myocardial Ischemia-Reperfusion Injury in Rabbit". Indian Journal of Pharmacology. 46 (2): 207–10. doi:10.4103/0253-7613.129320. PMC 3987192. PMID 24741195.
- Maresta, A; Balducelli, M; Cantini, L; Casari, A; Chioin, R; Fabbri, M; Fontanelli, A; Monici Preti, PA; Repetto, S; De Servi, S (December 1994). "Trapidil (triazolopyrimidine), a Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty. Results of the Randomized, Double-Blind STARC Study". Circulation. 90 (6): 2710–5. doi:10.1161/01.cir.90.6.2710. PMID 7994812.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.